Idylla ctNRAS-BRAF-EGFR S492R Mutation Assay (RUO)
A0091/6
The fully automated IdyllaTM ctNRAS-BRAF-EGFR S492R Mutation Assay is minimally invasive, fast and easy to perform. ctNRAS-BRAF-EGFR S492R covers 18 mutations in NRAS exons 2,3 and 4, 5 mutations in BRAF codon 600 as well as 2 EGFR mutations in codon 492 and showed an high concordance of 100% for NRAS as well as 99.5% for BRAF compared to NGS using plasma samples from 198 mCRC patients enrolled in the prospective multicenter RASANC study.1
For Research Use Only (RUO), not for use in diagnostic procedures.
For more information on the PlexZyme, PlexPrime, HiLyte and QXL licenses, click here.
Jacobs et al. Journal of Clinical Oncology 2017; 35,15_suppl e15127
Specimen requirements
One of the biggest challenges in oncology biomarker testing is the ability to obtain samples of sufficient size and quality. With the IdyllaTM System only a minimal amount of sample is needed
- 1 ml plasma collected using either EDTA or Streck tubes
NOTE:
- K2EDTA tubes: process within 4 hours
- Streck Cell-free BCTs: process within 3 days